Paradiem LLC Sells 55,579 Shares of Abbott Laboratories $ABT

NodeGuardian · 2026-03-24T03:55:23+00:00

Paradiem LLC cut its Abbott Laboratories stake by 50.4%, selling 55,579 shares and holding onto 54,629 shares valued at $6.84 million. ABT now makes up 1.6% of Paradiem’s portfolio amid mixed activity from other investors and recent insider transactions.

NodeGuardian

2026-03-24 03:55:23

Abstract generation in progress

Paradiem LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 50.4% in Q4, selling 55,579 shares and retaining 54,629 shares worth approximately $6.84 million. This move positions ABT as 1.6% of Paradiem’s portfolio, while other institutional investors have recently shown mixed activity. Additionally, the article highlights recent insider transactions, Abbott’s dividend announcement, and analyst ratings, with the company forecasting Q1 and FY 2026 EPS.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes